Search

everythinglearnresearchcommunity

for

Search:↓

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

New compounds may soon be tested to treat excessive hair growth in women.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Personalized treatment with inhibitors, minoxidil, and laser therapy helps hair loss.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

The research found that measuring androgens in urine can give extra information about body metabolism and is linked to androgen levels in the blood, especially in young girls.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

The document explains how male reproductive hormones work and affect the body.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.